Brain Health in the Time of COVID-19
NCT04438967 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 10000
Last updated 2021-01-06
Summary
This is a nationwide research program to study the neurological effects of COVID-19. It is open to the public. Healthy individuals and individuals who are or have been infected with COVID-19 are encouraged to join the effort. The study can be done at home with internet access and an iPad or iPhone. Participation takes about one hour.
To learn more, go to https://www.mirohealth.com/consent/
Conditions
- Brain Health
Sponsors & Collaborators
- collaborator OTHER
-
University of Pittsburgh
collaborator OTHER -
Miro Health
lead OTHER
Principal Investigators
-
Natasha Belfor, PhD · Miro Health
-
Leah Rubin, PhD · Johns Hopkins University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-06-16
- Primary Completion
- 2021-12-31
- Completion
- 2021-12-31
Countries
- United States
Study Locations
More Related Trials
-
Humanity Neurotech Device Clinical Trial in Adults With Long COVID Cognitive Dysfunction
NCT06739668 ·Status: COMPLETED ·Phase: NA
-
Objective Brain Function Assessment of mTBI/Concussion
NCT03963804 ·Status: COMPLETED
-
Evaluation and Validation of a Multimodal Brain Function Biomarker With NPC
NCT04074486 ·Status: COMPLETED
-
Objective Concussion Assessment Using MRI and Metabolomics
NCT05993351 ·Status: RECRUITING
-
Neurodegeneration Markers and Neurological Course in Severe Covid-19 Infection
NCT04361344 ·Status: TERMINATED ·Phase: NA
-
Cognitive Impairment and Fatigue After Mild to Moderate COVID-19
NCT06042530 ·Status: RECRUITING
-
Neuropsychiatric Post-Acute Sequelae of SARS-CoV-2 (PASC) Using TSPO Positron Emission Tomography (PET) and MRI
NCT05615415 ·Status: ACTIVE_NOT_RECRUITING
-
PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
NCT04396873 ·Status: RECRUITING ·Phase: PHASE1
-
Imaging SARS-CoV-2 Involvement of Leptomeninges, Olfactory and Limbic Areas
NCT04448054 ·Status: COMPLETED
-
Systematic Assessment of SARS-CoV-2 Neurotropic Capacity in Modestly and Critically Ill Patients, and Patients Who Died From COVID-19
NCT04472013 ·Status: COMPLETED
-
Evaluating a Novel Method of EEG Evoked Response Potential Analysis in Concussion Assessment
NCT03265912 ·Status: COMPLETED
-
Precision Diagnosis of Acute Infectious Diseases; Neuroinflammatory Cohort
NCT02910037 ·Status: COMPLETED ·Phase: NA
-
Tau PET/CT Imaging in the Mismatch Prospective Cohort Study (MPC-TAU)
NCT05658913 ·Status: RECRUITING
-
Developing a New EEG Method for the Early Diagnosis of Dementia
NCT02426398 ·Status: RECRUITING
-
Biomarkers in Concussion
NCT05943561 ·Status: UNKNOWN
-
Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy Subjects
NCT02103894 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Neurological Damage From Coronavirus Disease (COVID-19)
NCT05079373 ·Status: UNKNOWN
-
Objective Brain Function Assessment of mTBI/Concussion in High School Athletes
NCT02661633 ·Status: COMPLETED
-
Determination of Acute Encephalopathy Predictors in Patients With COVID-19
NCT04405544 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Tau Protein in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants
NCT03239561 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Evaluation of [11C]RO6924963, [11C]RO6931643, and [18F]RO6958948 as Tracers for Positron Emission Tomography (PET) Imaging of Tau in Healthy and Alzheimer's Disease (AD) Participants
NCT02187627 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess Regional Cerebral Blood Flow as an Alzheimer's Disease Biomarker Compared to Positron Emission Tomography in Patients With Mild-to-Moderate Alzheimer's Disease and Cognitively Normal Elderly Subjects (Study MK-0000-068)(COMPLETED)
NCT00757939 ·Status: COMPLETED ·Phase: PHASE1
-
Cohort Follow-up of Epidemic and Neuroimaging for Patients During the 1st Wave of the COVID-19 in China
NCT05745805 ·Status: RECRUITING
-
Phase 0 Evaluation of [18F]MNI-958 as a Potential PET Radioligand for Imaging Tau Protein in the Brain
NCT03058965 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Evaluation of [18F] PBR06 and PET as a Marker of Inflammation in Subjects With Neurological Conditions
NCT01028209 ·Status: TERMINATED ·Phase: PHASE1